Standout Papers

The Epidemiology of Major Depressive Disorder 1996 2026 2006 2016 6.1k
  1. The Epidemiology of Major Depressive Disorder (2003)
    Ronald C. Kessler, Patricia A. Berglund et al. JAMA
  2. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006)
    A. John Rush, Madhukar H. Trivedi et al. American Journal of Psychiatry
  3. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression (2003)
    A. John Rush, Madhukar H. Trivedi et al. Biological Psychiatry
  4. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice (2006)
    Madhukar H. Trivedi, A. John Rush et al. American Journal of Psychiatry
  5. The Inventory of Depressive Symptomatology (IDS): psychometric properties (1996)
    A. John Rush, Christina M. Gullion et al. Psychological Medicine
  6. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS (2003)
    Scott A. Gerber, A. John Rush et al. Proceedings of the National Academy of Sciences
  7. Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome (2011)
    Woong Kim, Eric J. Bennett et al. Molecular Cell
  8. A probability-based approach for high-throughput protein phosphorylation analysis and site localization (2006)
    Sean A. Beausoleil, Judit Villén et al. Nature Biotechnology
  9. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells (2004)
    A. John Rush, Albrecht Moritz et al. Nature Biotechnology
  10. Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation (2009)
    Ping Xu, Duc M. Duong et al. Cell
  11. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation (2004)
    Madhukar H. Trivedi, A. John Rush et al. Psychological Medicine
  12. The inventory for depressive symptomatology (IDS): Preliminary findings (1986)
    A. John Rush, Donna E. Giles et al. Psychiatry Research
  13. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression (2006)
    A. John Rush, Madhukar H. Trivedi et al. New England Journal of Medicine
  14. Handbook of Psychiatric Measures (2000)
    A. John Rush, Michael B. First et al. Medical Entomology and Zoology
  15. Medication Augmentation after the Failure of SSRIs for Depression (2006)
    Madhukar H. Trivedi, Maurizio Fava et al. New England Journal of Medicine
  16. Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report (2008)
    Maurizio Fava, A. John Rush et al. American Journal of Psychiatry
  17. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients (1977)
    A. John Rush, Aaron T. Beck et al. Cognitive Therapy and Research
  18. When at first you don't succeed: sequential strategies for antidepressant nonresponders. (1997)
    M E Thase, A. John Rush PubMed
  19. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (2003)
    Charles B. Nemeroff, Christine Heim et al. Proceedings of the National Academy of Sciences
  20. Axis I Psychiatric Comorbidity and Its Relationship to Historical Illness Variables in 288 Patients With Bipolar Disorder (2001)
    S L McElroy, Trisha Suppes et al. American Journal of Psychiatry
  21. Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006)
    A. John Rush, Helena C. Kraemer et al. Neuropsychopharmacology
  22. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006)
    A. John Rush American Journal of Psychiatry
  23. Interpersonal Psychotherapy of Depression (1985)
    A. John Rush American Journal of Psychiatry
  24. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation (2013)
    Danielle L. Swaney, Pedro Beltrão et al. Nature Methods
  25. Bupropion and Naltrexone in Methamphetamine Use Disorder (2021)
    Madhukar H. Trivedi, Robrina Walker et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 29 from Science/Nature 112 standout
Sub-graph 1 of 20

Citing Papers

Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
2023 StandoutScienceNobel
7 intermediate papers

Works of A. John Rush being referenced

Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics
2010
A probability-based approach for high-throughput protein phosphorylation analysis and site localization
2006 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
A. John Rush 25423 23613 19237 896 84.9k
Maurizio Fava 23243 16618 15181 926 57.6k
Dennis S. Charney 16717 15533 11470 569 81.6k
Robin Murray 9363 41055 6941 1.5k 87.3k
Herta Flor 12493 9867 8144 1.3k 91.1k
Madhukar H. Trivedi 20422 13733 14520 739 49.2k
Charles B. Nemeroff 7815 9870 5885 931 74.2k
David J. Kupfer 8907 20400 18841 732 59.5k
John H. Krystal 12767 11029 6257 642 58.2k
Jim van Os 5310 35669 14918 1.1k 66.8k
Brenda W.J.H. Penninx 5388 10197 12487 975 71.2k

All Works

Loading papers...

Rankless by CCL
2026